Your browser doesn't support javascript.
loading
Albumin redox state of maintenance haemodialysis patients is positively altered after treatment.
Boss, Kristina; Paar, Margret; Waterstradt, Katja; Schnurr, Kerstin; Ickerott, Philipp; Wieneke, Ulrike; Spitthöver, Ralf; Oettl, Karl; Kribben, Andreas.
Afiliação
  • Boss K; Department of Nephrology, University Hospital Essen, University Duisburg-Essen, 45147, Essen, Germany. kristina.boss@uk-essen.de.
  • Paar M; Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
  • Waterstradt K; MedInnovation GmbH, Berlin, Germany.
  • Schnurr K; MedInnovation GmbH, Berlin, Germany.
  • Ickerott P; Gemeinschaftspraxis für Nieren- und Hochdruckkrankheiten Essen-Steele, Essen, Germany.
  • Wieneke U; Dialyse- und Lipid-Zentrum Nordrhein, Essen, Germany.
  • Spitthöver R; Dialyse- und Lipid-Zentrum Nordrhein, Essen, Germany.
  • Oettl K; Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
  • Kribben A; Department of Nephrology, University Hospital Essen, University Duisburg-Essen, 45147, Essen, Germany.
BMC Nephrol ; 24(1): 273, 2023 09 18.
Article em En | MEDLINE | ID: mdl-37723426
ABSTRACT
BACKGROUND AND

AIM:

Maintenance haemodialysis patients have increased morbidity and mortality which is mainly driven by an elevated inflammation level due to the uraemic milieu. A major part of this increased inflammation level is the degree of oxidative stress which can be assessed by albumin redox state (ARS). Aim of this study was to evaluate how the ARS is affected by a haemodialysis treatment and different dialyzer properties.

METHODS:

ARS was determined before and after haemodialysis treatment by fractionating it into reduced human mercaptalbumin (HMA), reversibly oxidized human non-mercaptalbumin 1 (HNA-1), and irreversibly oxidized human non-mercaptalbumin 2 (HNA-2) by high-performance liquid chromatography. In healthy individuals, albumin circulates in the following proportions HMA 70-80%, HNA-1 20-30% and HNA-2 2-5%. High flux (FX 100 [Fresenius Medical Care], BG 1.8 [Toray], Xevonta Hi 18 [B. Braun], CTA-2000 [Kawasumi]) and low flux FX10 [Fresenius Medical Care] dialyzers were used.

RESULTS:

58 patients (59% male, median age 68 years, median time on haemodialysis 32 month) were included in the study. Before haemodialysis treatment, HMA (median 55.9%, IQR 50.1-61.2%) was substantially lower than in healthy individuals. Accordingly, oxidized albumin fractions were above the level of healthy individuals (median HNA-1 38.5%, IQR 33.3-43.2%; median HNA-2 5.8%, IQR 5.1-6.7%). Before haemodialysis treatment HMA was significantly higher in patients usually treated with high flux membranes (p < 0.01). After haemodialysis treatment there was a significant increase of HMA and a decrease of HNA-1 and HNA-2 (p < 0.01). These effects were more pronounced in patients treated with high flux dialyzers (p < 0.01). There were no differences of ARS alteration with regard to the dialyzer´s sterilization mode or the presence of diabetes.

CONCLUSION:

The study confirms that the ARS is positively altered by haemodialysis and shows for the first time that this effect depends on dialyzer properties.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nível de Saúde / Inflamação Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nível de Saúde / Inflamação Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article